The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The FDA said it proposed significant changes to simplify biosimilarity studies and reduce what it described as unnecessary ...

The U.S. Food and Drug Administration (FDA) announced on Wednesday (October 29) a plan to streamline the approval process for ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

The US Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

Generic drugs feature the exact same active ingredient, strength and dosing regimen as their brand-name predecessors, but, if it weren’t for their typically lower prices, they still wouldn’t be many ...

The United States has said it will speed up approval for some generic drugs. The development comes weeks after it was ...